Genesee Capital Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,746
Closed -$525K 130
2021
Q4
$525K Sell
5,746
-16,173
-74% -$1.74M 0.25% 74
2021
Q3
$2.82M Buy
+21,919
New +$3.07M 1.39% 20
2021
Q2
Sell
-20,807
Closed -$2.19M 112
2021
Q1
$2.19M Sell
20,807
-860
-4% -$86.1K 1.3% 24
2020
Q4
$1.72M Buy
+21,667
New +$1.59M 1.12% 32

Other funds holding STAA

Genesee Capital Advisors's STAA Position: Q1 2022 in Review

Genesee Capital Advisors sold out of STAAR Surgical (STAA) in Q1 2022, closing a stake of 5,746 shares — an estimated $525K sold.

Genesee Capital Advisors first reported a position in STAA in Q4 2020 and held it in 4 quarters. The position peaked at $2.82M in Q3 2021. 270 funds tracked by Wall St. Rank hold STAA as of Q1 2022.

  • Genesee Capital Advisors reported no remaining STAAR Surgical position as of Q1 2022 after selling out during the quarter.
  • Genesee Capital Advisors sold 5,746 STAAR Surgical shares in Q1 2022, an estimated $525K.
  • Genesee Capital Advisors first reported a position in STAAR Surgical in Q4 2020 and held it in 4 quarters.
  • Genesee Capital Advisors's STAAR Surgical position peaked at $2.82M in Q3 2021.
  • 270 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2022.

Based on Genesee Capital Advisors's 13F filing for Q1 2022, filed 25 May 2022.